CORRECTION article

Front. Pharmacol., 16 September 2022

Sec. Experimental Pharmacology and Drug Discovery

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1034389

Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment

    ZW

    Zita Wachal 1

    AS

    Anna Szilágyi 1

    BT

    Barbara Takács 1

    AM

    Adrienn Mónika Szabó 1

    DP

    Dániel Priksz 1

    MB

    Mariann Bombicz 1

    JS

    Judit Szilvássy 2

    BJ

    Béla Juhász 1

    ZS

    Zoltán Szilvássy 1

    BV

    Balázs Varga 1‡ *

  • 1. Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

  • 2. Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

Article metrics

View details

1k

Views

470

Downloads

In the published article, there was an error in affiliation 1. Instead of “Department of Pharmacology and Pharmacotherapy, University of Debrecen, Debrecen, Hungary”, it should be “Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

diabetes, survival, ZDf, retinopathy, erg, BGP-15

Citation

Wachal Z, Szilágyi A, Takács B, Szabó AM, Priksz D, Bombicz M, Szilvássy J, Juhász B, Szilvássy Z and Varga B (2022) Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment. Front. Pharmacol. 13:1034389. doi: 10.3389/fphar.2022.1034389

Received

01 September 2022

Accepted

02 September 2022

Published

16 September 2022

Approved by

Frontiers in Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Balázs Varga,

†These authors have contributed equally to this work and share first authorship

‡These authors have contributed equally to this work and share last authorship

This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics